Of interest and article archive

Here you will find selected articles from our archive.
For historical articles, please see here.

Go back

August 1, 2024

Jasper Kurth has assumed the position as CEO

June 26, 2024

Thor Medical receives DSA authorization for production of alpha-emitters at Herøya pilot plant

June 11, 2024

Thor Medical releases updated investor presentation

June 6, 2024

Thor Medical signs Memorandum of Understanding for feedstock supply and technology cooperation

May 6, 2024

Primary insider trading

May 2, 2024

New share capital registered

April 23, 2024

Share option grant

April 21, 2024

Grant of restricted stock units (RSU) to the members of the board

April 21, 2024

Issuance of shares to members of the board

April 11, 2024

Minutes from the annual general meeting

April 11, 2024

Completion of annual general meeting

April 10, 2024

Business update from CEO in relation to the company’s AGM

Thor Medical logo

Contact
Thor Medical HQ

Drammensveien 167
NO-0277 Oslo, Norway
Org.no: 994 297 422
MVA

+ 47 974 14 000

(08.00-16.00 CET)

post@thormedical.com

Design and development by

NXT Oslo Reklamebyrå